Coach vs. Kors: Bat...
Health Care: Drugs
ACADIA Pharmaceuticals Inc. (ACAD: NASDAQ)
$1.33 0.02 | 1.53%
06/04/12 - 04:00 PM ET
Ratio Comparisons
| Company | Industry | S&P 500 | |
| Valuation Ratios | |||
|---|---|---|---|
| P/E Ratio (TTM) | n.a. | 75.30 | 17.70 |
| P/E High - Last 5 Yrs | n.a. | n.a. | 67.70 |
| P/E Low - Last 5 Yrs | n.a. | n.a. | 12.50 |
| Beta | 2.56 | 0.58 | 0.98 |
| Price to Sales (TTM) | 33.30 | 4.62 | 1.42 |
| Price to Book (MRQ) | 3.94 | 3.44 | 2.41 |
| Price to Tangible Book (MRQ) | 3.94 | 6.74 | 5.08 |
| Price to Cash Flow (TTM) | -3.00 | 26.10 | 9.80 |
| Price to Free Cash Flow (TTM) | -3.50 | 48.80 | 17.40 |
| Dividends | |||
| Dividend Yield (%) | 0.00 | 0.50 | 2.10 |
| Dividend Yield - 5 Yr Avg (%) | n.a. | 0.20 | 2.20 |
| Dividend 5 Yr Growth Rate (%) | n.a. | n.a. | -0.76 |
| Payout Ratio (TTM) | 0.00 | 3.00 | 30.00 |
| Sales (MRQ) vs Qtr 1 Yr Ago (%) | 3.40 | 9.90 | 11.80 |
| Sales (TTM) vs TTM 1 Yr Ago (%) | -95.10 | 7.70 | 9.20 |
| Growth Rates (%) | |||
| Sales - 5 Yr Growth Rate (%) | -3.63 | 9.03 | 1.79 |
| EPS (MRQ) vs Qtr 1 Yr Ago (%) | n.a. | 18.50 | 17.50 |
| EPS (TTM) vs TTM 1 Yr Ago (%) | n.a. | 18.50 | 17.50 |
| EPS - 5 Yr Growth Rate (%) | n.a. | n.a. | -1.66 |
| Capital Spending - 5 Yr Growth Rate (%) | n.a. | -4.13 | -1.17 |
| Financial Strength | |||
| Quick Ratio (MRQ) | 4.00 | 2.90 | 1.10 |
| Current Ratio (MRQ) | 4.10 | 3.50 | 1.60 |
| LT Debt to Equity (MRQ) | 0.00 | 0.41 | 0.82 |
| Total Debt to Equity (MRQ) | 0.00 | 0.45 | 0.96 |
| Interest Coverage (TTM) | n.a. | 6.20 | 5.50 |
| Profitability Ratios (%) | |||
| Gross Margin (TTM) | n.a. | 84.10 | 46.90 |
| Gross Margin - 5 Yr Avg | n.a. | 83.50 | 47.70 |
| EBITD Margin (TTM) | n.a. | 27.30 | 18.90 |
| EBITD - 5 Yr Avg | -323.38 | 0.00 | 0.00 |
| Pre-Tax Margin (TTM) | n.a. | 14.10 | 12.10 |
| Pre-Tax Margin - 5 Yr Avg | n.a. | 10.60 | 10.30 |
| Management Effectiveness (%) | |||
| Net Profit Margin (TTM) | -11.12 | 0.10 | 0.09 |
| Net Profit Margin - 5 Yr Avg | n.a. | 5.30 | 7.00 |
| Return on Assets (TTM) | -87.30 | 4.70 | 3.10 |
| Return on Assets - 5 Yr Avg | -54.30 | 2.20 | 2.50 |
| Return on Investment (TTM) | -131.00 | 6.10 | 7.90 |
| Return on Investment - 5 Yr Avg | -74.20 | 2.80 | 6.50 |
| Efficiency | |||
| Revenue/Employee (TTM) | 86,750.00 | 701,747.00 | 449,376.00 |
| Net Income/Employee (TTM) | -964,583.00 | 83,589.00 | 39,003.00 |
| Receivable Turnover (TTM) | n.a. | 5.80 | 7.60 |
| Inventory Turnover (TTM) | n.a. | 1.30 | 8.30 |
| Asset Turnover (TTM) | 0.10 | 0.40 | 0.40 |
Portfolios with ACAD
- Portfolio NameUser Type
- Contributor22 Biopharma Stocks With Br...
- ContributorStocks Under-$10 Moving Hig...
- ContributorStocks Under-$10 Moving Hig...
- ContributorStocks Under-$10 Moving Hig...
- UserBerliner
- Contributor5 Stocks Under-$10 Setting ...
- Contributor10 Pharma Stocks Under $3
- Userazfar
- UserMy Portfolio
- UserNUKE PORTFOLIO
Latest ACAD Headlines from TheStreet
- 22 Biopharma Stocks With Breakout Potential in 2012 05.22.12 | 08:05 am
- ACADIA Stock Gaps Down On Today's Open (ACAD) 04.26.12 | 09:04 am
- ACADIA Pharmaceuticals Inc. Stock Downgraded (ACAD) 04.11.12 | 05:04 am
- 8 Stocks Under $10 Moving Higher 03.20.12 | 12:03 pm
- ACADIA Stock Soars (ACAD) 03.13.12 | 03:03 pm
- 5 Stocks Under $5 Making Big Moves 03.13.12 | 02:03 pm
- ACADIA Stock Soars (ACAD) 01.18.12 | 04:01 pm
- 7 Stocks Under $10 Ripping Higher 12.20.11 | 02:12 pm
- Acadia Pharmaceuticals: Investing With No Safety Net 06.24.11 | 10:06 am
- 10 Pharma Stocks Under $3 06.16.11 | 01:06 pm
Press Releases for ACAD
- ACADIA Pharmaceuticals To Webcast Educational Program On Parkinson’s Disease Psychosis On May 22, 2012 - Business Wire 05.15.12 | 09:05 am
- ACADIA Pharmaceuticals Reports First Quarter 2012 Financial Results - Business Wire 05.08.12 | 04:05 pm
- ACADIA Pharmaceuticals To Present At The 19th Annual Future Leaders In The Biotech Industry Conference On April 20, 2012 - Business Wire 04.13.12 | 09:04 am
- ACADIA Pharmaceuticals To Present At The 11th Annual Needham Healthcare Conference On April 3, 2012 - Business Wire 03.28.12 | 09:03 am
- ACADIA Pharmaceuticals Awarded New Grant From The Michael J. Fox Foundation For Development Of Nurr1-RXR Selective Agonists To Treat Parkinson’s Disease - Business Wire 03.27.12 | 09:03 am
- ACADIA Pharmaceuticals Reports Financial Results For The Fourth Quarter And Year Ended December 31, 2011 - Business Wire 03.06.12 | 04:03 pm
- ACADIA Pharmaceuticals Announces Extension Of Drug Discovery Collaboration With Allergan, Inc. - Business Wire 03.05.12 | 09:03 am
- ACADIA Pharmaceuticals To Present At Upcoming Investor Conferences - Business Wire 02.29.12 | 09:02 am
- ACADIA Pharmaceuticals To Announce Fourth Quarter And Full Year 2011 Financial Results On March 6, 2012 - Business Wire 02.28.12 | 09:02 am
- ACADIA Pharmaceuticals To Present At The 14th Annual BIO CEO & Investor Conference On February 13, 2012 - Business Wire 02.06.12 | 09:02 am
Partner Headlines for ACAD
- Time To Take Another Look At The Biotechnology Sector - Seeking Alpha 04.09.12 | 09:04 am
- Why Antares Pharma Should Be On Your List For Long-Term Investment - Seeking Alpha 03.16.12 | 08:03 am
- Bio-Pharma Watch List: 2 Week Report Card - Seeking Alpha 03.12.12 | 09:03 am
- 7 Healthcare Stocks Undervalued By Earnings Growth And Cash Flows - Seeking Alpha 02.03.12 | 07:02 pm
- Zacks #1 Rank Additions for Wednesday - Tale of the Tape - Zacks 01.25.12 | 09:01 am
- Zacks #1 Rank Additions for Monday - Tale of the Tape - Zacks 01.23.12 | 09:01 am
- Zacks #1 Rank Additions for Thursday - Tale of the Tape - Zacks 01.19.12 | 09:01 am
- Zacks #1 Rank Additions for Tuesday - Tale of the Tape - Zacks 01.17.12 | 09:01 am
- Zacks #1 Rank Additions for Friday - Tale of the Tape - Zacks 01.13.12 | 09:01 am
- 10 Biotech Stocks Undervalued By Levered Free Cash Flows - Seeking Alpha 12.07.11 | 08:12 am
